{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:43:32Z","timestamp":1790721812756,"version":"4.1.0"},"reference-count":11,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,11,18]],"date-time":"2002-11-18T00:00:00Z","timestamp":1037577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2002,12]]},"abstract":"<jats:p><jats:bold>Summary.<\/jats:bold> Agnogenic myeloid metaplasia (AMM) is characterized by bone marrow fibrosis with abnormal accumulation of extracellular matrix components (ECM), which is dependent on the balance between matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). Twenty\u2010five patients with AMM, 30 with essential thrombocythemia (ET), 12 with polycythemia vera (PV) and 20 normal control subjects were studied. AMM patients had decreased plasma levels of MMP\u20103 and marked elevated levels of TIMP\u20101, but MMP\u20101, MMP\u20102 and MMP\u20109 levels were not significantly different from control subjects. Elevated levels of plasma TIMP\u20101, but not MMPs, were found in ET and PV. Reduced MMP activity together with increased TIMP\u20101 activity may be essential in fibrosis formation.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2002.03874.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:48:58Z","timestamp":1047365338000},"page":"709-712","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Plasma matrix metalloproteinase and tissue inhibitor of metalloproteinase in patients with agnogenic myeloid metaplasia or idiopathic primary myelofibrosis"],"prefix":"10.1111","volume":"119","author":[{"given":"Jen C.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiva","family":"Novetsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan D.","family":"Novetsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,11,18]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.24.14313"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-209-43886a"},{"key":"e_1_2_9_4_1","first-page":"427","volume-title":"Myelofibrosis and the Biology of Connective Tissue","author":"Castro\u2010Malaspina H.","year":"1984"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1999.01352.x"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0955-2235(89)90012-4"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199109064872"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.3293146.x"},{"key":"e_1_2_9_9_1","first-page":"347a","article-title":"Plasma VEGF levels in patients with primary myelofibrosis and other myeloproliferative disorders","volume":"90","author":"Novetsky A.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_9_10_1","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.4049\/jimmunol.153.6.2819","article-title":"Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines. Potential role for interleukin\u20101 and TGF\u2010\u03b2","volume":"153","author":"Rameshwar P.","year":"1994","journal-title":"Journal of Immunology"},{"key":"e_1_2_9_11_1","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood.V75.7.1540.1540","article-title":"The production of transforming growth factor\u2010\u03b2 in acute megakaryoblastic leukemia and its possible implication in myelofibrosis","volume":"75","author":"Terui T.","year":"1990","journal-title":"Blood"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400846"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03874.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03874.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2002.03874.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:30:20Z","timestamp":1697380220000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2002.03874.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11,18]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["10.1046\/j.1365-2141.2002.03874.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03874.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11,18]]},"assertion":[{"value":"2002-11-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}